Novavax Inc (NASDAQ: NVAX) stock enjoyed a major increase of 10.3% on 1/6/25. The shares closed at $9.76. Moreover, trading volume in this advance was unusually high at 178% of normal. The stock has performed in line with the market over the last nine months and has risen 15.2% during the last week.
Current PriceTarget Research Rating
Novavax is currently unrated.
Rating Review
The stock is currently unrated.
Be the first to comment